Pharvaris Nv (PHVS)

May 05, 2026

Pharvaris Insider Sold Shares Worth $427,419, According to a Recent SEC Filing - marketscreener.com

May 05, 2026

May 05, 2026

Pharvaris (PHVS) CMO exercises $2.59 options, sells 14,166 shares under 10b5-1 plan - Stock Titan

May 05, 2026

May 04, 2026

Pharvaris N.v. Insider Sold Shares Worth $996,545, According to a Recent SEC Filing - Moomoo

May 04, 2026

May 03, 2026

Behavioral Patterns of PHVS and Institutional Flows - Stock Traders Daily

May 03, 2026

May 03, 2026

Should New Deucrictibant Data on Dual HAE Use Require Action From Pharvaris (PHVS) Investors? - Sahm

May 03, 2026

May 02, 2026

For Pharvaris Investors, the Director's Sale Matters Less Than What's Coming Next - AOL.com

May 02, 2026

May 01, 2026

Peng Lu Sells 15,000 Shares of Pharvaris (NASDAQ:PHVS) Stock - MarketBeat

May 01, 2026

May 01, 2026

Anne Lesage Sells 3,700 Shares of Pharvaris (NASDAQ:PHVS) Stock - MarketBeat

May 01, 2026

May 01, 2026

Pharvaris (NASDAQ:PHVS) Director Sells $115,168.10 in Stock - MarketBeat

May 01, 2026

May 01, 2026

Johannes Gerardus Chri Schikan Sells 29,070 Shares of Pharvaris (NASDAQ:PHVS) Stock - MarketBeat

May 01, 2026

May 01, 2026

Insider Selling: Pharvaris (NASDAQ:PHVS) Insider Sells 21,700 Shares of Stock - MarketBeat

May 01, 2026

May 01, 2026

Director at Pharvaris (NASDAQ: PHVS) trims stake via preset 10b5-1 sales - Stock Titan

May 01, 2026

May 01, 2026

Pharvaris (PHVS) exec Lesage sells 48K shares, exercises options - Stock Titan

May 01, 2026

May 01, 2026

Planned 18,733-share sale by Pharvaris (PHVS) chief medical officer - Stock Titan

May 01, 2026

May 01, 2026

Pharvaris (NASDAQ:PHVS) Shares Down 6%Should You Sell? - MarketBeat

May 01, 2026

May 01, 2026

Pharvaris moves closer to new preventive treatment for rare swelling disorder - MSN

May 01, 2026

Apr 30, 2026

Pharvaris Director Schikan Sells $213K in Shares Under Rule 10b5-1 PlanNews and Statistics - IndexBox

Apr 30, 2026

Apr 30, 2026

Pharvaris (NASDAQ:PHVS) Hits New 12-Month HighTime to Buy? - MarketBeat

Apr 30, 2026

Apr 29, 2026

For Pharvaris Investors, the Director's Sale Matters Less Than What's Coming Next - The Motley Fool

Apr 29, 2026

Apr 29, 2026

Pharvaris (NASDAQ:PHVS) Sees Large Volume IncreaseWhat's Next? - MarketBeat

Apr 29, 2026

Apr 29, 2026

Chiesi snags on-demand HAE drug in $1.9B Kalvista buy - BioWorld News

Apr 29, 2026

Apr 27, 2026

Pharvaris N.V. (NASDAQ:PHVS) Short Interest Update - MarketBeat

Apr 27, 2026

Apr 27, 2026

PHVS Pharvaris N.V. shares climb nearly 5 percent despite fourth quarter 2025 earnings missing analyst estimates.GDR - Newser

Apr 27, 2026

Apr 27, 2026

Does Pharvaris (PHVS) have the potential to rally 59.93% as Wall Street analysts expect? - MSN

Apr 27, 2026

Apr 24, 2026

Insider Selling: Pharvaris (NASDAQ:PHVS) Director Sells 7,000 Shares of Stock - MarketBeat

Apr 24, 2026

Apr 24, 2026

Insider Selling: Pharvaris (NASDAQ:PHVS) Insider Sells 7,500 Shares of Stock - MarketBeat

Apr 24, 2026

Apr 24, 2026

[Form 4] Pharvaris N.V. Insider Trading Activity - Stock Titan

Apr 24, 2026

Apr 24, 2026

Pharvaris (NASDAQ:PHVS) Insider Sells $210,380.05 in Stock - MarketBeat

Apr 24, 2026

Apr 24, 2026

Pharvaris (NASDAQ:PHVS) Shares Gap Down Following Insider Selling - MarketBeat

Apr 24, 2026

Apr 24, 2026

Pharvaris (PHVS) CMO trades shares in scheduled 10b5-1 option exercise - Stock Titan

Apr 24, 2026

Apr 24, 2026

Pharvaris Insider Sold Shares Worth $441,726, According to a Recent SEC Filing - marketscreener.com

Apr 24, 2026

Apr 23, 2026

Pharvaris (NASDAQ:PHVS) Sets New 1-Year HighHere's Why - MarketBeat

Apr 23, 2026

Apr 22, 2026

(PHVS) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily

Apr 22, 2026

Apr 22, 2026

Pharvaris N.V. (PHVS) Stock Technical Analysis | Q4 2025: Below ExpectationsRating Upgrade - Xã Thanh Hà

Apr 22, 2026

Apr 22, 2026

[144] Pharvaris N.V. SEC Filing - Stock Titan

Apr 22, 2026

Apr 22, 2026

Is Evidence Backing Dual Deucrictibant Use Altering The Investment Case For Pharvaris (PHVS)? - Sahm

Apr 22, 2026

Apr 20, 2026

Pharvaris presents safety data on combined deucrictibant use By Investing.com - Investing.com Australia

Apr 20, 2026

Apr 20, 2026

Pharvaris N.V. (PHVS) CMO reports 226-share tax withholding event - Stock Titan

Apr 20, 2026

Apr 20, 2026

Pharvaris (NASDAQ:PHVS) CEO Berndt Modig Sells 2,292 Shares - MarketBeat

Apr 20, 2026

Apr 20, 2026

Pharvaris (PHVS) CEO sells 2,292 shares but retains large stake - Stock Titan

Apr 20, 2026

Apr 20, 2026

Pharvaris says one drug may cover both HAE prevention and breakthrough attacks - Stock Titan

Apr 20, 2026

Apr 17, 2026

Pharvaris (NASDAQ:PHVS) Reaches New 12-Month HighShould You Buy? - MarketBeat

Apr 17, 2026

Apr 17, 2026

Peng Lu Net Worth (2026) - GuruFocus

Apr 17, 2026

Apr 17, 2026

Anne Lesage Net Worth (2026) - GuruFocus

Apr 17, 2026

Apr 17, 2026

Pharvaris N.V. (PHVS) Presents at CIIC Spring 2026 ConferenceSlideshow (NASDAQ:PHVS) 2026-04-17 - Seeking Alpha

Apr 17, 2026

Apr 17, 2026

Pharvaris N.V. (PHVS) Stock Analysis: Exploring a 62.93% Upside Potential in the Biotech Sector - DirectorsTalk Interviews

Apr 17, 2026

Apr 17, 2026

RBC Capital initiates coverage of Pharvaris NV (PHVS) with outperform recommendation - MSN

Apr 17, 2026

Apr 16, 2026

Affiliate files Rule 144 to sell 2,292 shares (PHVS) — prior 23,333-share 10b5-1 sale - Stock Titan

Apr 16, 2026

Apr 15, 2026

PHVS Maintained at Buy by Citigroup, April 2026 - Meyka

Apr 15, 2026

Apr 14, 2026

Pharvaris (PHVS) officer has shares withheld to cover RSU tax obligations - Stock Titan

Apr 14, 2026

Apr 14, 2026

Anna Nijdam Net Worth (2026) - GuruFocus

Apr 14, 2026

Apr 13, 2026

Pharvaris' CEO Dumped Over 23,000 Company Shares. Here's What That Means for Investors. - AOL.com

Apr 13, 2026

Apr 13, 2026

Pharvaris' Chief Executive Officer Sold More Than 23,000 Shares. What Does This Indicate for Shareholders? - Bitget

Apr 13, 2026